Karuna Therapeutics Inc. (KRTX) PT Raised to $167 at JMP Securities, 'Additional Evidence Continues to Support KarXT's Advantages'
Tweet Send to a Friend
JMP Securities analyst Jason Butler raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $167.00 (from $122.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
